Cargando…

Responsiveness of outcome measures in myotonic dystrophy type 1

OBJECTIVE: As myotonic dystrophy type 1(DM1) evolves slowly and interventional trials often have a short duration, responsive outcomes in DM1 are needed. The objective of this study was to determine the responsiveness of muscle strength, balance, and functional mobility measurements after a 1‐year f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knak, Kirsten L., Sheikh, Aisha M., Witting, Nanna, Vissing, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448158/ https://www.ncbi.nlm.nih.gov/pubmed/32672404 http://dx.doi.org/10.1002/acn3.51129

Ejemplares similares

Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy—A 1-Year Follow-Up Study
por: Sheikh, Aisha M., et al.
Publicado: (2021)

Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of DMPK in Patients with Myotonic Dystrophy Type 1
por: Hildonen, Mathis, et al.
Publicado: (2020)

Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study
por: Petri, Helle, et al.
Publicado: (2014)

Patients With Becker Muscular Dystrophy Have Severe Paraspinal Muscle Involvement
por: Sheikh, Aisha M., et al.
Publicado: (2021)

Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype
por: Witting, Nanna, et al.
Publicado: (2011)

High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1
por: Rasmussen, Astrid, et al.
Publicado: (2022)

Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
por: Montagnese, Federica, et al.
Publicado: (2020)

Altered somatosensory neurovascular response in patients with Becker muscular dystrophy
por: Lindberg, Ulrich, et al.
Publicado: (2018)

Aerobic anti‐gravity exercise in patients with Charcot–Marie–Tooth disease types 1A and X: A pilot study
por: Knak, Kirsten L., et al.
Publicado: (2017)

Analysis of the functional capacity outcome measures for myotonic dystrophy
por: Jimenez‐Moreno, Aura Cecilia, et al.
Publicado: (2019)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mahadevan, Mani S., et al.
Publicado: (2021)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1
por: Winkler, Nelson S., et al.
Publicado: (2018)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Myotonic Dystrophy Type 1 Presenting as Male Infertility
por: Kim, Woong Bin, et al.
Publicado: (2012)

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013)

Prevalence and correlates of apathy in myotonic dystrophy type 1
por: Gallais, Benjamin, et al.
Publicado: (2015)

Imaging in Myotonic Dystrophy Type 1 – Case Reports
por: Bielen, Jurgen, et al.
Publicado: (2016)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

Basilar Artery Dissection in Myotonic Dystrophy Type 1
por: Lee, Chan-Hyuk, et al.
Publicado: (2022)

Benefits of aerobic exercise in myotonic dystrophy type 1
por: Mackenzie, Samuel J., et al.
Publicado: (2022)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1
por: Davey, Emily E., et al.
Publicado: (2023)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1
por: Simoncini, Costanza, et al.
Publicado: (2020)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Muscle contractility in spinobulbar muscular atrophy
por: Dahlqvist, Julia R., et al.
Publicado: (2019)

Structural white matter networks in myotonic dystrophy type 1
por: van Dorst, Maud, et al.
Publicado: (2018)

Respiratory failure in myotonic dystrophy 1
Publicado: (2013)

Senescence plays a role in myotonic dystrophy type 1
por: García-Puga, Mikel, et al.
Publicado: (2022)

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
por: López-Morató, Marta, et al.
Publicado: (2018)

Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
por: Urata, Yuka, et al.
Publicado: (2020)

Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates
por: Winblad, Stefan, et al.
Publicado: (2010)

Molecular Genetics and Genetic Testing in Myotonic Dystrophy Type 1
por: Savić Pavićević, Dušanka, et al.
Publicado: (2013)

Pulmonary thromboembolism in a patient with myotonic dystrophy type 1
por: Cho, Joong-Yang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d88nt2o0uu7msa3madrlocvc2f